Literature DB >> 27558570

Individualized Approaches Are Needed for Optimized Blood Cultures.

Ritu Banerjee1, Volkan Özenci2, Robin Patel3,4.   

Abstract

Many strategies and technologies are available to improve blood culture (BC)-based diagnostics. The ideal approach to BCs varies between healthcare institutions. Institutions need to examine clinical needs and practices in order to optimize BC-based diagnostics for their site. Before laboratories consider offering rapid matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-ToF MS) or expensive rapid panel-based molecular BC diagnostics, they should optimize preanalytical, analytical, and postanalytical processes and procedures surrounding BC systems. Several factors need to be considered, including local resistance rates, antibiotic prescribing patterns, patient- and provider-types, laboratory staffing, and personnel available to liaise with clinicians to optimize antibiotic use. While there is much excitement surrounding new high-technology diagnostics, cost-neutral benefits can be realized by optimizing existing strategies and using available tools in creative ways. Rapid BC diagnostics should be implemented in a manner that optimizes impact. Strategies to optimize these BC diagnostics in individual laboratories are presented here.
© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  bacteremia; blood culture

Mesh:

Year:  2016        PMID: 27558570      PMCID: PMC5091349          DOI: 10.1093/cid/ciw573

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  39 in total

1.  An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia.

Authors:  Karri A Bauer; Jessica E West; Joan-Miquel Balada-Llasat; Preeti Pancholi; Kurt B Stevenson; Debra A Goff
Journal:  Clin Infect Dis       Date:  2010-11-01       Impact factor: 9.079

2.  Impact of mecA gene testing and intervention by infectious disease clinical pharmacists on time to optimal antimicrobial therapy for Staphylococcus aureus bacteremia at a University Hospital.

Authors:  Peggy L Carver; Shu-Wen Lin; Daryl D DePestel; Duane W Newton
Journal:  J Clin Microbiol       Date:  2008-05-07       Impact factor: 5.948

3.  Outcomes of rapid identification for gram-positive bacteremia in combination with antibiotic stewardship at a community-based hospital system.

Authors:  Maggie J Box; Eva L Sullivan; Kristine N Ortwine; Mark A Parmenter; Michael M Quigley; Louise M Aguilar-Higgins; Cynthia L MacIntosh; Kristina F Goerke; Rachel A Lim
Journal:  Pharmacotherapy       Date:  2015-03       Impact factor: 4.705

4.  Comparison of 2 blood culture media shows significant differences in bacterial recovery for patients on antimicrobial therapy.

Authors:  Rebecca Zadroga; David N Williams; Richard Gottschall; Kevan Hanson; Vickie Nordberg; Marcia Deike; Mike Kuskowski; Lisa Carlson; David P Nicolau; Christina Sutherland; Glen T Hansen
Journal:  Clin Infect Dis       Date:  2012-12-07       Impact factor: 9.079

5.  Antibiotic utilization improvement with the Nanosphere Verigene Gram-Positive Blood Culture assay.

Authors:  Stacy G Beal; Cody Thomas; Neelam Dhiman; Daniel Nguyen; Huanying Qin; Jennifer M Hawkins; Mhair Dekmezian; Raul Benavides
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-04

6.  Prospective intervention study with a microarray-based, multiplexed, automated molecular diagnosis instrument (Verigene system) for the rapid diagnosis of bloodstream infections, and its impact on the clinical outcomes.

Authors:  Hiromichi Suzuki; Shigemi Hitomi; Yuji Yaguchi; Kiyoko Tamai; Atsuo Ueda; Kazuhiro Kamata; Yasuharu Tokuda; Hiroshi Koganemaru; Yoko Kurihara; Hiroichi Ishikawa; Hideji Yanagisawa; Katsunori Yanagihara
Journal:  J Infect Chemother       Date:  2015-10-23       Impact factor: 2.211

Review 7.  Computer-assisted decision support for the diagnosis and treatment of infectious diseases in intensive care units.

Authors:  C A M Schurink; P J F Lucas; I M Hoepelman; M J M Bonten
Journal:  Lancet Infect Dis       Date:  2005-05       Impact factor: 25.071

8.  Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs.

Authors:  Katherine K Perez; Randall J Olsen; William L Musick; Patricia L Cernoch; James R Davis; Geoffrey A Land; Leif E Peterson; James M Musser
Journal:  Arch Pathol Lab Med       Date:  2012-12-06       Impact factor: 5.534

9.  Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship.

Authors:  Rebecca R Roberts; Bala Hota; Ibrar Ahmad; R Douglas Scott; Susan D Foster; Fauzia Abbasi; Shari Schabowski; Linda M Kampe; Ginevra G Ciavarella; Mark Supino; Jeremy Naples; Ralph Cordell; Stuart B Levy; Robert A Weinstein
Journal:  Clin Infect Dis       Date:  2009-10-15       Impact factor: 9.079

10.  Clinical and economic impact of antimicrobial stewardship interventions with the FilmArray blood culture identification panel.

Authors:  Joe Pardo; Kenneth P Klinker; Samuel J Borgert; Brittany M Butler; Patricia G Giglio; Kenneth H Rand
Journal:  Diagn Microbiol Infect Dis       Date:  2015-11-11       Impact factor: 2.803

View more
  20 in total

1.  MASTERMIND: Bringing Microbial Diagnostics to the Clinic.

Authors:  Robin Patel; Ephraim L Tsalik; Elizabeth Petzold; Vance G Fowler; Jeffrey D Klausner; Scott Evans
Journal:  Clin Infect Dis       Date:  2016-12-07       Impact factor: 9.079

2.  Rapid Direct Susceptibility Testing from Positive Blood Cultures by the Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry-Based Direct-on-Target Microdroplet Growth Assay.

Authors:  Evgeny A Idelevich; Luise M Storck; Katrin Sparbier; Oliver Drews; Markus Kostrzewa; Karsten Becker
Journal:  J Clin Microbiol       Date:  2018-09-25       Impact factor: 5.948

3.  Diagnostic Stewardship: Opportunity for a Laboratory-Infectious Diseases Partnership.

Authors:  Robin Patel; Ferric C Fang
Journal:  Clin Infect Dis       Date:  2018-08-16       Impact factor: 9.079

Review 4.  Syndromic Panel-Based Testing in Clinical Microbiology.

Authors:  Poornima Ramanan; Alexandra L Bryson; Matthew J Binnicker; Bobbi S Pritt; Robin Patel
Journal:  Clin Microbiol Rev       Date:  2017-11-15       Impact factor: 26.132

5.  Evaluation of the Accelerate Pheno System: Results from Two Academic Medical Centers.

Authors:  Joseph D Lutgring; Cassiana Bittencourt; Erin McElvania TeKippe; Dominick Cavuoti; Rita Hollaway; Eileen M Burd
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

Review 6.  Practical Guidance for Clinical Microbiology Laboratories: A Comprehensive Update on the Problem of Blood Culture Contamination and a Discussion of Methods for Addressing the Problem

Authors:  Gary V Doern; Karen C Carroll; Daniel J Diekema; Kevin W Garey; Mark E Rupp; Melvin P Weinstein; Daniel J Sexton
Journal:  Clin Microbiol Rev       Date:  2019-10-30       Impact factor: 26.132

7.  Impact of a Rapid Blood Culture Diagnostic Test in a Children's Hospital Depends on Gram-Positive versus Gram-Negative Organism and Day versus Night Shift.

Authors:  Lillian J Juttukonda; Sophie Katz; Jessica Gillon; Jonathon Schmitz; Ritu Banerjee
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

Review 8.  Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach.

Authors:  Matteo Bassetti; Garyphallia Poulakou; Etienne Ruppe; Emilio Bouza; Sebastian J Van Hal; Adrian Brink
Journal:  Intensive Care Med       Date:  2017-07-21       Impact factor: 17.440

9.  Single-Sampling Strategy vs. Multi-Sampling Strategy for Blood Cultures in Sepsis: A Prospective Non-inferiority Study.

Authors:  David Yu; Anna Larsson; Åsa Parke; Christian Unge; Claes Henning; Jonas Sundén-Cullberg; Anna Somell; Kristoffer Strålin; Volkan Özenci
Journal:  Front Microbiol       Date:  2020-07-23       Impact factor: 5.640

10.  Rapid microbial identification and antimicrobial susceptibility testing to drive better patient care: an evolving scenario.

Authors:  Volkan Özenci; Gian Maria Rossolini
Journal:  J Antimicrob Chemother       Date:  2019-01-01       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.